BIO-VED Pharmaceuticals, Inc., based in San Jose, California, USA is committed to the discovery, development, pre-clinical and clinical testing, and marketing of proprietary plant based pharmaceuticals, nutraceuticals and OTC (Over The Counter) products for difficult to treat diseases in human beings. BIO-VED's lead products, ARTREX ^® Capsules and Cream are indicated in the treatment of rheumatoid arthritis, osteoarthritis and other forms of non-infectious, inflammatory and degenerative arthritis. ARTREX^®  Cream is the first ever product from the science of Ayurveda to have received a US FDA (United States Food and Drug Administration) approval under the OTC Analgesic Monograph. ARTREX^® Capsules have received a US Patent.

Through its state of the art facility, based in India, The BIO-VED Research Center provides a spectrum of contract research services in Drug Discovery and Development for international companies. These include chemistry, pre-clinical, clinical and toxicology studies. The Center provides rapid, customized analysis and reports using innovative information technology and laboratory testing menus for pharmaceutical and biotechnology companies.

BIO-VED has established marketing partners over three continents of the world and in countries as wide as United States, Canada, Russia, Ukraine, South Africa, Middle East, Singapore, and Malaysia, among others. BIO-VED seeks to expand marketing of its lead and pipeline products to other countries of the globe through strategic partnerships and licensing arrangements.